Related references
Note: Only part of the references are listed.Combinatorial biosynthesis for the generation of new-to-nature peptide antimicrobials
Fleur Ruijne et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs)
Yuxin Fu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Engineering of new-to-nature ribosomally synthesized and post-translationally modified peptide natural products
Chunyu Wu et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Nisin- and Ripcin-Derived Hybrid Lanthipeptides Display Selective Antimicrobial Activity against Staphylococcus aureus
Xinghong Zhao et al.
ACS SYNTHETIC BIOLOGY (2021)
BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity
Xinghong Zhao et al.
FRONTIERS IN MICROBIOLOGY (2021)
New developments in RiPP discovery, enzymology and engineering
Manuel Montalban-Lopez et al.
NATURAL PRODUCT REPORTS (2021)
Substrate Recognition by the Class II Lanthipeptide Synthetase HaIM2
Imran R. Rahman et al.
ACS CHEMICAL BIOLOGY (2020)
An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium
Xinghong Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB
Xinghong Zhao et al.
ACS SYNTHETIC BIOLOGY (2020)
Characterization of two relacidines belonging to a novel class of circular lipopeptides that act against Gram-negative bacterial pathogens
Zhibo Li et al.
ENVIRONMENTAL MICROBIOLOGY (2020)
Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification
Xinghong Zhao et al.
CELL CHEMICAL BIOLOGY (2020)
Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale
Steven Schmitt et al.
NATURE CHEMICAL BIOLOGY (2019)
Discovery of New Thioviridamide-Like Compounds with Antitumor Activities
Yuqing Li et al.
CHINESE JOURNAL OF CHEMISTRY (2019)
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase
Bo Ma et al.
NATURE COMMUNICATIONS (2019)
Current developments in lantibiotic discovery for treating Clostridium difficile infection
Stephanie Kate Sandiford
EXPERT OPINION ON DRUG DISCOVERY (2019)
Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
Cristina Brunati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The roles of antimicrobial peptide, rip-thanatin, in the midgut of &ITRiptortus pedestris&IT
Kyoung-Eun Park et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2018)
Investigation of Substrate Recognition and Biosynthesis in Class IV Lanthipeptide Systems
Julian D. Hegemann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens
Qian Li et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
Yong-Xin Li et al.
NATURE COMMUNICATIONS (2018)
Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli
Stefan U. Vetterli et al.
SCIENCE ADVANCES (2018)
Chimeric Leader Peptides for the Generation of Non-Natural Hybrid RiPP Products
Brandon J. Burkhart et al.
ACS CENTRAL SCIENCE (2017)
Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials
Manuel Montalban-Lopez et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes
Lindsay M. Repka et al.
CHEMICAL REVIEWS (2017)
Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies
Elvis Legala Ongey et al.
BIOTECHNOLOGY LETTERS (2017)
Nonribosomal Peptide Synthesis-Principles and Prospects
Roderich D. Suessmuth et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
A Lanthipeptide-like N-Terminal Leader Region Guides Peptide Epimerization by Radical SAM Epimerases: Implications for RiPP Evolution
Sebastian W. Fuchs et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Recent advances in engineering nonribosomal peptide assembly lines
M. Winn et al.
NATURAL PRODUCT REPORTS (2016)
Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2016)
Perspectives on lantibiotic discovery - where have we failed and what improvements are required?
Stephanie Kate Sandiford
EXPERT OPINION ON DRUG DISCOVERY (2015)
Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound
Timo Koopmans et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Bioengineering Lantibiotics for Therapeutic Success
Des Field et al.
FRONTIERS IN MICROBIOLOGY (2015)
Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB
Manuel A. Ortega et al.
NATURE (2015)
The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics
Jerome Escano et al.
MICROBIOLOGYOPEN (2014)
Site-Directed Mutations in the Lanthipeptide Mutacin 1140
Shaorong Chen et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)
NisC Binds the FxLx Motif of the Nisin Leader Peptide
Andre Abts et al.
BIOCHEMISTRY (2013)
The Future of Peptide-based Drugs
David J. Craik et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes
Auke J. van Heel et al.
ACS SYNTHETIC BIOLOGY (2013)
New horizons for host defense peptides and lantibiotics
Michael John Dawson et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Bioengineered nisin derivatives with enhanced activity in complex matrices
Susan Rouse et al.
MICROBIAL BIOTECHNOLOGY (2012)
Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive Pathogens
Daniela Jabes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Requirements of the Engineered Leader Peptide of Nisin for Inducing Modification, Export, and Cleavage
Annechien Plat et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Nine Post-translational Modifications during the Biosynthesis of Cinnamycin
Ayse Oekesli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Determining sites of interaction between prenisin and its modification enzymes NisB and NisC
Rustem Khusainov et al.
MOLECULAR MICROBIOLOGY (2011)
Activity and Export of Engineered Nisin-(1-22) Analogs
Annechien Plat et al.
POLYMERS (2011)
Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
Clare Piper et al.
MICROBIAL BIOTECHNOLOGY (2011)
In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
Carl Urban et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide
Sylwia Rodziewicz-Motowidlo et al.
FEBS JOURNAL (2010)
Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
Leon D. Kluskens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II
Hester E. Hasper et al.
SCIENCE (2006)
Round and round we go: Cyclic peptides in disease
Maria Katsara et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Optimization and applications of CDAP labeling for the assignment of cysteines
GD Pipes et al.
PHARMACEUTICAL RESEARCH (2005)
Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes
R Rink et al.
BIOCHEMISTRY (2005)
Antimicrobial peptides: New candidates in the fight against bacterial infections
O Toke
BIOPOLYMERS (2005)
Antimicrobial peptides in animals and their role in host defences
KA Brogden et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005
DA Widdick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
